Bubbles Themes Watchlists Portfolios Universe Today News Alerts Research Articles Bots About

Daily digest

One email a day · alerts + bubble shifts · free during beta.

About Alerts Research Support ♡Disclosures Terms Privacy FR PT API Follow on X

US equities · Daily close · Refreshed nightly 22:30 Paris

Not investment advice. QuantAbundancia is educational research only. Nothing on this site is a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Full disclosures.

We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.

News

High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

2,486 signal articles · 200 in last 24h · 10,656 total before filter · latest 44m ago

200last 24h

1888last 7d

375🟢 bullish (7d)

178🔴 bearish (7d)

114publishers

All 🌍 Macro165 📊 Earnings1085 🤝 M&A81 ⚖️ Regulatory23 🚀 Product15 📈 Analyst16

✕ clear all filtersticker: NVAXsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Zacks2d agobullish

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Novavax (NVAX) delivered earnings and revenue surprises of +75.68% and +100.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

NVAX